Sit Investment Associates’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384K Buy
13,430
+2,535
+23% +$80.5K 0.01% 423
2026
Q1
$343K Hold
10,895
0.01% 417
2025
Q4
$321K Hold
10,895
0.01% 431
2025
Q3
$275K Hold
10,895
0.01% 433
2025
Q2
$261K Sell
10,895
-11,170
-51% -$259K 0.01% 445
2025
Q1
$505K Buy
22,065
+787
+4% +$19K 0.01% 411
2024
Q4
$539K Hold
21,278
0.01% 418
2024
Q3
$530K Hold
21,278
0.01% 431
2024
Q2
$631K Buy
21,278
+3,590
+20% +$99.6K 0.01% 395
2024
Q1
$533K Buy
17,688
+2,040
+13% +$56.6K 0.01% 404
2023
Q4
$448K Buy
15,648
+6,655
+74% +$195K 0.01% 421
2023
Q3
$333K Buy
8,993
+8,144
+959% +$311K 0.01% 423
2023
Q2
$33K Hold
849
﹤0.01% 529
2023
Q1
$31K Buy
+849
New +$26.8K ﹤0.01% 517

Other funds holding RTO

Sit Investment Associates's RTO Position: Q2 2026 in Review

Sit Investment Associates increased its Rentokil (RTO) stake by 23% in Q2 2026, buying an estimated $80.5K and bringing the position to 13,430 shares worth $384K. The position accounts for 0.01% of the portfolio, ranked #423.

Sit Investment Associates first reported a position in RTO in Q1 2023 and has held it in 14 quarters since. The position peaked at $631K in Q2 2024. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Sit Investment Associates held 13,430 shares of Rentokil worth $384K as of Q2 2026.
  • Sit Investment Associates bought 2,535 Rentokil shares in Q2 2026, an estimated $80.5K.
  • Rentokil made up 0.01% of Sit Investment Associates's portfolio in Q2 2026, its #423 holding.
  • Sit Investment Associates first reported a position in Rentokil in Q1 2023 and has held it in 14 quarters since.
  • Sit Investment Associates's Rentokil position peaked at $631K in Q2 2024.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.